The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Estimating progression to cirrhosis in chronic hepatitis C virus infection
Abstract
To gain a clearer understanding of the rate of progression to cirrhosis and its determinants in chronic hepatitis C virus (HCV) infection, a systematic review of published epidemiologic studies that incorporated assessment for cirrhosis has been undertaken. Inclusion criteria were more than 20 cases of chronic HCV infection, and information on either age of subjects or duration of infection. Of 145 studies examined, 57 fulfilled the inclusion criteria. Least-squares linear regression was employed to estimate rates of progression to cirrhosis, and to examine for factors associated with more rapid disease progression in 4 broad study categories: 1) liver clinic series (number of studies = 33); 2) posttransfusion cohorts (n = 5); 3) blood donor series (n = 10); and 4) community-based cohorts (n = 9). Estimates of progression to cirrhosis after 20 years of chronic HCV infection were 22% (95% CI, 18%-26%) for liver clinic series, 24% (11%-37%) for posttransfusion cohorts, 4% (1%-7%) for blood donor series, and 7% (4%-10%) for community-based cohorts. Factors that were associated with more rapid disease progression included older age at HCV infection, male gender, and heavy alcohol intake. Even after accounting for these factors, progression estimates were much higher for cross-sectional liver clinic series. Selection biases probably explain the higher estimates of disease progression in this group of studies. Community-based cohort studies are likely to provide a more representative basis for estimating disease progression at a population level. These suggest that for persons who acquire HCV infection in young adulthood, less than 10% are estimated to develop cirrhosis within 20 years. (Hepatology 2001;34:809-816.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural history of liver fibrosis progression in patients with chronic hepatitis C
Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011
Classification of chronic hepatitis: Diagnosis, grading and staging
Desmet, V. J., Gerber, M., Hoofnagle, J. H., Manns, M., & Scheuer, P. J. (1994) · Hepatology · doi:10.1002/hep.1840190629 · Cited by 2,593
The Natural History of Community-Acquired Hepatitis C in the United States
Alter, M. J., Margolis, H. S., Krawczynski, K., Judson, F. N., Mares, A., Alexander, W. J., Hu, P. Y., Miller, J. K., Gerber, M. A., Sampliner, R. E., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272702 · Cited by 1,592
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients
Benhamou, Y., Bochet, M., Di Martino, V., Charlotte, F., Azria, F., Coutellier, A., Vidaud, M., Bricaire, F., Opolon, P., Katlama, C., et al. (1999) · Hepatology · doi:10.1002/hep.510300409 · Cited by 1,219
Kiyosawa, K., Sodeyama, T., Tanaka, E., Gibo, Y., Yoshizawa, K., Nakano, Y., Furuta, S., Akahane, Y., Nishioka, K., Purcell, R. H., et al. (1990) · Hepatology · doi:10.1002/hep.1840120409 · Cited by 1,217
Clinical Outcomes after Transfusion-Associated Hepatitis C
Tong, M. J., El-Farra, N. S., Reikes, A. R., & Co, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506013322202 · Cited by 1,198
The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors
Thomas, D. L., Astemborski, J., Rai, R. M., Anania, F. A., Schaeffer, M., Galai, N., Nolt, K., Nelson, K. E., Strathdee, S. A., Johnson, L., et al. (2000) · JAMA · doi:10.1001/jama.284.4.450 · Cited by 1,073
Clinical Outcomes after Hepatitis C Infection from Contaminated Anti-D Immune Globulin
Kenny-Walsh, E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904223401602 · Cited by 910
Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C
Liang, T. J., Rehermann, B., Seeff, L. B., & Hoofnagle, J. H. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-4-200002150-00008 · Cited by 868
Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis
Seeff, L. B., Buskell-Bales, Z., Wright, E. C., Durako, S. J., Alter, H. J., Iber, F. L., Hollinger, F. B., Gitnick, G., Knodell, R. G., Perrillo, R. P., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272703 · Cited by 672
Prognosis of Chronic Hepatitis C: Results of A Large, Prospective Cohort Study
Niederau, C., Lange, S., Heintges, T., Erhardt, A., Buschkamp, M., Hürter, D., Nawrocki, M., Kruska, L., Hensel, F., Petry, W., et al. (1998) · Hepatology · doi:10.1002/hep.510280632 · Cited by 636
Conry-Cantilena, C., VanRaden, M., Gibble, J., Melpolder, J., Shakil, A. O., Viladomiu, L., Cheung, L., DiBisceglie, A., Hoofnagle, J., Shih, J. W., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342602 · Cited by 627
Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis
di Bisceglie, A. M., Goodman, Z. D., Ishak, K. G., Hoofnagle, J. H., Melpolder, J. J., & Alter, H. J. (1991) · Hepatology · doi:10.1002/hep.1840140603 · Cited by 539
Prevalence of chronic liver disease in the general population of northern Italy: The dionysos study
Bellentani, S., Tiribelli, C., Saccoccio, G., Sodde, M., Fratti, N., De Martin, C., & Christianini, G. (1994) · Hepatology · doi:10.1002/hep.1840200611 · Cited by 517
Vogt, M. O., Lang, T., Frösner, G., Klingler, C., Sendl, A., Zeller, A., Wiebecke, B., Langer, B., Meisner, H., & Hess, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411202 · Cited by 502
Persistence of Viremia and the Importance of Long–Term Follow–Up After Acute Hepatitis C Infection
Villano, S. A., Vlahov, D., Nelson, K. E., Cohn, S., & Thomas, D. L. (1999) · Hepatology · doi:10.1002/hep.510290311 · Cited by 475
Impact of alcohol on the histological and clinical progression of Hepatitis C infection
Wiley, T. E., McCarthy, M., Breidi, L., McCarthy, M., & Layden, T. J. (1998) · Hepatology · doi:10.1002/hep.510280330 · Cited by 436
Natural history of hepatitis C
Seeff, L. B. (1997) · Hepatology · doi:10.1002/hep.510260704 · Cited by 409
Determinants of outcome of compensated hepatitis C virus-related cirrhosis
Serfaty, L., Aumaître, H., Chazouillères, O., Bonnand, A.-M., Rosmorduc, O., Poupon, R. E., & Poupon, R. Y. (1998) · Hepatology · doi:10.1002/hep.510270535 · Cited by 403
Wiese, M., Berr, F., Lafrenz, M., Porst, H., & Oesen, U. (2000) · Hepatology · doi:10.1053/jhep.2000.8169 · Cited by 349
45-Year Follow-up of Hepatitis C Virus Infection in Healthy Young Adults
Seeff, L. B., Miller, R. N., Rabkin, C. S., Buskell-Bales, Z., Straley-Eason, K. D., Smoak, B. L., Johnson, L. D., Lee, S. R., & Kaplan, E. L. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-2-200001180-00003 · Cited by 347
Pessione, F., Degos, F., Marcellin, P., Duchatelle, V., Njapoum, C., Martinot-Peignoux, M., Degott, C., Valla, D., Erlinger, S., & Rueff, B. (1998) · Hepatology · doi:10.1002/hep.510270635 · Cited by 340
Bennett, W. G., Inoue, Y., Beck, J. R., Wong, J. B., Pauker, S. G., & Davis, G. L. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-10-199711150-00001 · Cited by 315
Mathurin, P., Moussalli, J., Cadranel, J.-F., Thibault, V., Charlotte, F., Dumouchel, P., Cazier, A., Huraux, J.-M., Devergie, B., Vidaud, M., et al. (1998) · Hepatology · doi:10.1002/hep.510270333 · Cited by 302
Roudot-Thoraval, F., Bastie, A., Pawlotsky, J., & Dhumeaux, D. (1997) · Hepatology · doi:10.1002/hep.510260233 · Cited by 297
High Rate of Infectivity and Liver Disease in Blood Donors with Antibodies to Hepatitis C Virus
Esteban, R., López-Talavera, J. C., Genescà, J., Madoz, P., Viladomiu, L., Muñiz‐Díaz, E., Martin-Vega, C., Rosell, M., Allende, H., Vidal, X., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-6-443 · Cited by 296
Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis
Tremolada, F., Casarin, C., Alberti, A., Drago, C., Tagger, A., Ribero, M. L., & Realdi, G. (1992) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80657-9 · Cited by 263
Shakil, A. O., Conry-Cantilena, C., Alter, H. J., Hayashi, P., Kleiner, D. E., Tedeschi, V., Krawczynski, K., Conjeevaram, H. S., Sallie, R., Bisceglie, A. M. D., et al. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-5-199509010-00002 · Cited by 254
Silini, E., Bono, F., Cividini, A., Cerino, A., Bruno, S., Rossi, S., Belloni, G., Brugnetti, B., Civardi, E., Salvaneschi, L., et al. (1995) · Hepatology · doi:10.1002/hep.1840210204 · Cited by 252
Bonacini, M., Hadi, G., Govindarajan, S., & Lindsay, K. L. (1997) · PubMed · Cited by 250
The natural course of chronic hepatitis C
Iwarson, S. (1994) · FEMS Microbiology Reviews · doi:10.1016/0168-6445(94)90033-7 · Cited by 238
Non-A, Non-B Post-Transfusion Hepatitis: Looking Back in the Second Decade
Koretz, R. L., Abbey, H., Coleman, E., & Gitnick, G. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-2-199307150-00003 · Cited by 233
Modeling the Hepatitis C Virus Epidemic in France
Deuffic, S., Buffat, L., Poynard, T., & Valleron, A.-J. (1999) · Hepatology · doi:10.1002/hep.510290528 · Cited by 210
Rodger, A. J., Roberts, S., Lanigan, A., Bowden, S., Brown, T., & Crofts, N. (2000) · Hepatology · doi:10.1053/jhep.2000.9714 · Cited by 182
Which patients with hepatitis C develop liver complications?
Khan, M. H., Farrell, G. C., Byth, K., Lin, R., Weltman, M., George, J., Samarasinghe, D., Kench, J., Kaba, S., Crewe, E., et al. (2000) · Hepatology · doi:10.1002/hep.510310236 · Cited by 160
Benvegnù, L. (1997) · Hepatology · doi:10.1053/jhep.1997.v25.pm0008985292 · Cited by 152
NON-A, NON-B POST-TRANSFUSION HEPATITIS
Dienstag, J. L., Purcell, R., Alter, H. J., Feinstone, S., Wong, D., & Holland, P. V. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91996-1 · Cited by 128
Epidemiology and long term prognosis of hepatitis C virus infection in Japan.
Yano, M., Yatsuhashi, H., INOUE, O., Inokuchi, K., & Koga, M. (1993) · Gut · doi:10.1136/gut.34.2_suppl.s13 · Cited by 125
Prieto, M., Olaso, V., Verdú, C., Córdoba, J., Gisbert, C., Rayón, M., Carrasco, D., Berenguer, M., Higón, M. D., & Berenguer, J. (1995) · Hepatology · doi:10.1002/hep.1840220207 · Cited by 116
Healey, C. J., Chapman, R. W., & Fleming, K. A. (1995) · Gut · doi:10.1136/gut.37.2.274 · Cited by 115
Mattsson, L., Sönnerborg, A. B., & Weiland, O. (1993) · Liver International · doi:10.1111/j.1600-0676.1993.tb00644.x · Cited by 108
Moliner, L. D., Pontisso, P., Salvo, G. L. D., et al. (1998) · Gut · doi:10.1136/gut.42.6.856 · Cited by 108
Shindo, M. (1995) · Hepatology · doi:10.1016/0270-9139(95)90560-x · Cited by 100
Risk factors and predictors of outcome in an Australian cohort with hepatitis C virus infection
Strasser, S. I., Watson, K. J. R., Desmond, P. V., Lee, C. S., & Coghlan, P. (1995) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1995.tb139937.x · Cited by 64
Historical patterns of prolonged hepatitis C infection
Roberts, J. M., Searle, J. W., & Cooksley, W. G. E. (1993) · Gastroenterologia Japonica · doi:10.1007/bf02989202 · Cited by 58
Luo, J., Hwang, S., Lai, C., Lu, C., Li, C., Tsay, S., WU, J., Chang, F., & LEE, S. (1998) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1998.tb00714.x · Cited by 47
Hepatitis C virus genotypes: epidemiological and clinical associations
Kleter, B., Brouwer, J. T., Nevens, F., van Doorn, L., Elewaut, A., Versieck, J., Michielsen, P. P., Hautekèete, M., Chamuleau, R. A. F. M., Brenard, R., et al. (1998) · Liver International · doi:10.1111/j.1600-0676.1998.tb00124.x · Cited by 46
Serfaty, L., Nousbaum, J. B., Elghouzzi, M. H., Giral, P., Legendre, C., & Poupon, R. Y. (1995) · Hepatology · doi:10.1002/hep.1840210319 · Cited by 42
Histological evolution of chronic hepatitis C. Factors related to progression
Vaquer, P., Canet, R., Llompart, A., Riera, J., Obrador, A., & Gayà, J. (1994) · Liver International · doi:10.1111/j.1600-0676.1994.tb00086.x · Cited by 41
Chronic hepatitis in United Kingdom blood donors infected with hepatitis C virus
Irving, W. L., Neal, K. R., Underwood, J. C. E., Peter Simmonds, K., & James, V. (1994) · BMJ · doi:10.1136/bmj.308.6930.695 · Cited by 35
Importance of age in chronic hepatitis C virus infection
Wong, V., Caronia, S., Wight, D. G. D., Palmer, C., Petrík, J., Britton, P. D., & Alexander, G. (1997) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.1997.00054.x · Cited by 33
Factors associated with severity and disease progression in chronic hepatitis C.
Tassopoulos, N., Papatheodoridis, G., Katsoulidou, A., Delladetsima, J. K., Sypsa, V., Touloumi, G., Nikandros, M., & Hatzakis, A. (1998) · PubMed · Cited by 25
A retrospective study of hepatitis C virus carriers in a local endemic town in Japan
Ohkoshi, S., Tawaraya, H., Kuwana, K., Harada, T., Watanabe, M., HIGUCHI, S., Kojima, H., Kamimura, T., & Asakura, H. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02065436 · Cited by 24
Gruber, A., Norder, H., Magnius, L. O., Rotzén, M., Rubio‐Terres, C., Grillner, L., & Björkholm, M. (1993) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058462 · Cited by 23
Rodger, A., Thomson, J., Thompson, S., Jolley, D., Mijch, A. M., Lanigan, A., & Crofts, N. (1999) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.1999.01846.x · Cited by 19
Epidemiology, serological markers, and hepatic disease of anti-HCV ELISA-2-positive blood donors
Salmerón, F. J., Palacios, A., Pérez-Ruiz, M., Torres, C., Oyonarte, S., Fernández-Montoya, A., & Ruiz‐Extremera, A. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02093592 · Cited by 13
Severity of liver disease in hepatitis C infection contracted through injecting drug use
Ostapowicz, G., Bell, S., & Desmond, P. V. (1999) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1999.tb00779.x · Cited by 11
Epidemiological risk factors and clinico-pathological presentation in chronic hepatitis C.
Iacono, O. L., Decastro, M., Garcı́a-Buey, L., García‐Monzón, C., Borque, M. J., Sanz, P., Garcia-Sanchez, A., & Moreno‐Otero, R. (1998) · PubMed · Cited by 6
Cited by
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
El-Serag, H. B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.061 · Cited by 3,380
Mohd Hanafiah, K., Groeger, J., Flaxman, A. D., & Wiersma, S. T. (2013) · Hepatology · doi:10.1002/hep.26141 · Cited by 2,515
Natural history of chronic hepatitis C
Seeff, L. B. (2002) · Hepatology · doi:10.1053/jhep.2002.36806 · Cited by 1,424
The global burden of hepatitis C
Lavanchy, D. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01934.x · Cited by 1,368
Metadata
- Authors
- Freeman, A. J., Dore, G. J., Law, M. G., Thorpe, M., Von Overbeck, J., Lloyd, A. R., Marinos, G., & Kaldor, J. M.
- Venue
- Hepatology
- Published
- 2001-10
- Volume
- 34
- Issue
- 4
- Pages
- 809-816
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2047556186
- Cited by
- 620
- References
- 58
- FWCI
- 18.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.